Research Progress on the Pathological Mechanisms of Podocytes in Diabetic Nephropathy
Lili Zhang,Zhige Wen,Lin Han,Yujiao Zheng,Yu Wei,Xinmiao Wang,Qing Wang,Xinyi Fang,Linhua Zhao,Xiaolin Tong
DOI: https://doi.org/10.1155/2020/7504798
IF: 4.0608
2020-07-10
Journal of Diabetes Research
Abstract:Diabetic nephropathy (DN) is not only an important microvascular complication of diabetes but also the main cause of end-stage renal disease. Studies have shown that the occurrence and development of DN are closely related to morphological and functional changes in podocytes. A series of morphological changes after podocyte injury in DN mainly include podocyte hypertrophy, podocyte epithelial-mesenchymal transdifferentiation, podocyte detachment, and podocyte apoptosis; functional changes mainly involve podocyte autophagy. More and more studies have shown that multiple signaling pathways play important roles in the progression of podocyte injury in DN. Here, we review research progress on the pathological mechanism of morphological and functional changes in podocytes associated with DN, to provide a new target for delaying the occurrence and development of this disorder.
endocrinology & metabolism,medicine, research & experimental
What problem does this paper attempt to address?
The problem that this paper attempts to address is the pathological mechanisms of podocytes in diabetic nephropathy (DN). Specifically, the article explores the pathological mechanisms of morphological and functional changes in podocytes during the occurrence and development of diabetic nephropathy, including phenomena such as podocyte hypertrophy, epithelial-mesenchymal transition (EMT), podocyte detachment, and podocyte apoptosis. These changes are associated with abnormal activities in various signaling pathways, such as mTOR, AMPK, oxidative stress, Sirt1, the Atg12-Atg5 conjugation system, and vascular endothelial growth factor (VEGF) signaling pathways. By reviewing these research advancements, the article aims to provide new targets for delaying the onset and progression of diabetic nephropathy.